Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings
EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) reported fourth-quarter net sales of $805.0 million and full-year net sales of $3.074 billion for 2025, both increases from the prior …
Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings Read More